Following up on the investigation started with Medicamentalia.org in 2015, we aim to tackle the complex issue of vaccine prices and how they affect the prevalence of specific illnesses in the developing world.
We will investigate the many stakeholders involved in the development, marketing and delivery of vaccines and immunisation plans. To that purpose, we’ll use multimedia and data visualization techniques to explain the problem from different perspectives and how the life prospects of millions of people around the world are affected.
Our stories will focus on:
- Which is the relation between levels of immunisation, the prevalence of related diseases and the prices of vaccines for the 12 basic WHO vaccines?
- How are vaccine prices set? A review of the current development and patent system as well as the international vaccine market.
- The international community has implemented different financial schemes to support countries in the procurement of vaccines. Are they being effective?
- What alternatives exist to traditional development and marketing strategies of vaccines?
The team will visit health centres, labs and distribution areas to understand, first hand, how the prices of vaccines affect the patients and how greater access to them could be a radical change in the quality of life of many citizens.
- Medicamentalia (EN/ES)
- Medicamentalia: Vaccination levels - Holes in the shield (EN/ES)
- Medicamentalia: Anti-Vaccines - When the problem is not just a question of resources (EN/ES)
- Medicamentalia: Successes - Facing diseases since the 18th Century (EN/ES)
- Medicamentalia: Vaccines that don't arrive (EN/ES)
- Medicamentalia: Team and methodology (EN/ES)
- Euronews: How Europe's vaccine scepticism is harming fight to rid the world of measles (EN)
- Euroscientist: Vaccination levels: holes in the shield (EN)
- El Mundo: Investigación periodística sobre la brecha global en el acceso a la salud (ES)
- La Sexta: Casi 22 millones de lactantes no reciben las vacunas básicas (ES)
- La Sexta: La mitad de los países del mundo no alcanza niveles de inmunización suficientes para frenar enfermedades como el sarampión (ES)